tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Eden Research Wins First South American Approval for Novellus+ in Chile

Story Highlights
  • Eden Research gained Chilean approval for its fungicide Novellus+ on grapes.
  • This first South American authorisation opens a key, growing market for Eden’s sustainable crop solutions.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Eden Research Wins First South American Approval for Novellus+ in Chile

Claim 70% Off TipRanks Premium

An announcement from Eden Research ( (GB:EDEN) ) is now available.

Eden Research has secured its first regulatory authorisation in South America with the approval of its fungicide Novellus+ in Chile for use on wine and table grapes to control grey mould and powdery mildew. The product, which offers residue-free protection and can be applied up to one day before harvest, will be exclusively distributed by Sipcam Chile SpA in a market that is both a global leader in wine and grape exports and a rapidly growing adopter of biological crop protection. This authorisation marks a strategic milestone for Eden, opening access to a sizable and expanding Chilean crop protection market and positioning the company to benefit from the country’s regulatory and industry push toward more sustainable agricultural practices, with plans to extend Novellus+ to additional high-value crops over time.

The most recent analyst rating on (GB:EDEN) stock is a Hold with a £2.50 price target. To see the full list of analyst forecasts on Eden Research stock, see the GB:EDEN Stock Forecast page.

Spark’s Take on GB:EDEN Stock

According to Spark, TipRanks’ AI Analyst, GB:EDEN is a Neutral.

Eden Research’s stock score is primarily impacted by its financial performance, which shows revenue growth but significant profitability and cash flow challenges. Technical analysis indicates short-term bullish momentum, but overbought signals suggest caution. The valuation is weak due to negative earnings and lack of dividends.

To see Spark’s full report on GB:EDEN stock, click here.

More about Eden Research

Eden Research plc is an AIM-listed company specialising in sustainable biopesticide and biocontrol technologies for agriculture. Its products focus on providing residue-free, environmentally friendly crop protection solutions, targeting high-value markets where growers and exporters face increasing pressure to adopt organic and biological alternatives to conventional chemical pesticides.

Average Trading Volume: 328,123

Technical Sentiment Signal: Sell

Current Market Cap: £14.4M

See more data about EDEN stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1